Citigroup Maintains Neutral on Bruker, Raises Price Target to $44

Benzinga Newsdesk www.benzinga.com Positive 54.1%

Neg 0% Neu 0% Pos 54.1%

Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $40 to $44.